Learn / LTGO
NASDAQ: LTGO
Latigo Biotherapeutics (LTGO) stock, explained like you're 5
Latigo Biotherapeutics trades on the Nasdaq under the ticker LTGO. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.1 billion dollars.
- Ticker
- LTGO
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 1.1 billion dollars
Is Latigo Biotherapeutics a small, medium or large cap company?
No. Latigo Biotherapeutics is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.1 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Latigo Biotherapeutics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves LTGO stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Latigo Biotherapeutics (LTGO) Stock Price, News & Analysis (Stock Titan)
- Latigo Biotherapeutics, Inc. (LTGO) stock price, news, quote and history (Yahoo Finance UK)
- Latigo Biotherapeutics (NASDAQ:LTGO) Stock Rating Cut to Sell at Wall Street Zen (MarketBeat)
- symbol__ Stock Quote Price and Forecast (CNN)
- Vertex Built The NaV1.8 Market, Latigo May Be The One To Profit From It (NASDAQ:LTGO) (Seeking Alpha)
Follow LTGO in your daily brief
Each trading day at 5 PM ET we post what happened to Latigo Biotherapeutics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow LTGO
Questions about Latigo Biotherapeutics stock
What does Latigo Biotherapeutics do?
Latigo Biotherapeutics trades on the Nasdaq under the ticker LTGO. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.1 billion dollars.
What is the ticker symbol for Latigo Biotherapeutics?
Latigo Biotherapeutics trades under the ticker LTGO on the Nasdaq.
What is Latigo Biotherapeutics's market cap?
Latigo Biotherapeutics is a small cap stock with a market cap of about 1.1 billion dollars.
How does Latigo Biotherapeutics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves LTGO stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow LTGO stock every day?
Add LTGO to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.